Other News

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Rhythm by Comments are Disabled

ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking MAGiC Sweep™ catheter. MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology (EP) mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.

Continue Reading →

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Financial by Comments are Disabled

Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the fiscal year ended April 30, 2025, and provided a business update highlighting significant strategic progress.

Continue Reading →

GNT Pharma Receives Regulatory Approval to Initiate Multinational Phase 3 Clinical Trials for its Breakthrough Stroke Therapy ‘ Nelonemdaz™ ‘

Neuro by Comments are Disabled

NEW YORK, July 24, 2025 /PRNewswire/ — GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 Clinical Trials of its lead drug Nelonemdaz, has been approved by MFDS – South Korea’s…

Continue Reading →

Heart Failure Society of America Celebrates 30 Years with Lineup of Visionary Leaders at Annual Scientific Meeting 2025

Coronary/Structural Heart by Comments are Disabled

Saturday Plenary to Spotlight Innovations in Heart Failure Research, AI, and Future Care Models WASHINGTON, July 24, 2025 /PRNewswire/ — The Heart Failure Society of America (HFSA) is marking 30 years of leadership in heart failure care with a dynamic celebration at the HFSA Annual…

Continue Reading →

AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology

Radiology by 0 comments

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of […]

Continue Reading →

Imperative Care Secures FDA Clearance and Initial Cases of the Zoom 7X Catheter, the Newest Innovation in Ischemic Stroke Treatment

Neuro by 0 comments

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]

Continue Reading →

Vektor Medical’s vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care

Rhythm by 0 comments

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. As adoption of PFA accelerates, the need […]

Continue Reading →
1 … 105 106 107 108 109 … 1,339